Feksofenadin: Perbedaan antara revisi
Konten dihapus Konten ditambahkan
Tidak ada ringkasan suntingan Tag: halaman dengan galat kutipan Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
Tidak ada ringkasan suntingan Tag: Suntingan perangkat seluler Suntingan peramban seluler Suntingan seluler lanjutan |
||
Baris 93:
}}
'''Feksofenadin'''<ref name=Brands>{{cite web|title=Fexofenadine - international brand names|url=https://www.drugs.com/international/fexofenadine.html|publisher=Drugs.com|access-date=18 January 2017}}</ref> adalah obat [[antihistamin]] yang digunakan dalam pengobatan gejala alergi, seperti [[rinitis alergi]] dan [[urtikaria]].<ref>{{cite journal | vauthors = Bachert C | title = A review of the efficacy of desloratadine, fexofenadine, and levocetirizine in the treatment of nasal congestion in patients with allergic rhinitis | journal = Clinical Therapeutics | volume = 31 | issue = 5 | pages = 921–944 | date = May 2009 | pmid = 19539095 | doi = 10.1016/j.clinthera.2009.05.017 }}</ref>
Secara terapeutik, feksofenadin adalah penghambat H<sub>1</sub> perifer selektif. Obat ini diklasifikasikan sebagai antihistamin generasi kedua karena kurang mampu melewati [[sawar darah otak]] dan menyebabkan sedasi, dibandingkan antihistamin generasi pertama.<ref name="rhin11">{{cite journal | vauthors = Compalati E, Baena-Cagnani R, Penagos M, Badellino H, Braido F, Gómez RM, Canonica GW, Baena-Cagnani CE | title = Systematic review on the efficacy of fexofenadine in seasonal allergic rhinitis: a meta-analysis of randomized, double-blind, placebo-controlled clinical trials | journal = International Archives of Allergy and Immunology | volume = 156 | issue = 1 | pages = 1–15 | date = 2011 | pmid = 21969990 | doi = 10.1159/000321896 | doi-access = free }}</ref><ref name="rhin1">{{cite journal | vauthors = Dicpinigaitis PV, Gayle YE | title = Effect of the second-generation antihistamine, fexofenadine, on cough reflex sensitivity and pulmonary function | journal = British Journal of Clinical Pharmacology | volume = 56 | issue = 5 | pages = 501–504 | date = November 2003 | pmid = 14651723 | pmc = 1884387 | doi = 10.1046/j.1365-2125.2003.01902.x }}</ref>
| |||